COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,196 Articles (22,713 medRxiv, 8,483 bioRxiv)

Most recent first Previous |  Page 1602: Articles 16011-16020  | Next

Effect of multiple freeze-thaw cycles on detection of anti-SARS-CoV-2 IgG antibodies
Shurrab, F. M., Al-Sadeq, D. W., Amanullah, F., Younes, S. N., Al-Jighefee, H., Younes, N., Dargham, S. R., YASSINE, H. M., Abu-Raddad, L. J., Nasrallah, G. K.
10.1101/2021.04.13.21255379 — Posted: 2021-04-19
Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand
Carlton, L. H., Chen, T., Whitcombe, A. L., McGregor, R., Scheurich, G., Sheen, C. R., Dickson, J. M., Bullen, C., Chiang, A., Exeter, D. J., Paynter, J., Baker, M. G., Charlewood, R., Moreland, N. J.
10.1101/2021.04.12.21255282 — Posted: 2021-04-19
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
Fulford, T. S., Van, H., Gherardin, N. A., Zheng, S., Ciula, M., Drummer, H. E., Redmond, S., Tan, H.-X., Center, R. J., Li, F., Grimley, S. L., Wines, B. D., Nguyen, T. H., Mordant, F. L., Rowntree, L. C., Cheng, A. C., Doola, D. L., Bond, K., Hogarth, P. M., McQuilten, Z., Subbarao, K., Kedzierska, K., Juno, J. A., Wheatley, A. K., Kent, S. J., Williamson, D. A., Purcell, D. F. J., Anderson, D. A., Godfrey, D. I.
10.1101/2021.04.12.21255368 — Posted: 2021-04-19
The increase in the risk of severity and fatality rate of covid-19 in southern Brazil after the emergence of the Variant of Concern (VOC) SARS-CoV-2 P.1 was greater among young adults without pre-existing risk conditions
Freitas, A. R. R., Lemos, D. R. Q., Beckedorff, O. A., Cavalcante, L. P. G., Siqueira, A. M., Mello, R. C. S., Barros, E. N. C.
10.1101/2021.04.13.21255281 — Posted: 2021-04-19
Strategies and action points to ensure equitable uptake of COVID-19 vaccinations: A national qualitative interview study to explore the views of undocumented migrants, asylum seekers, and refugees
Deal, A., Hayward, S. E., Huda, M., Knights, F., Crawshaw, A. F., Carter, J., Hassan, O. B., Farah, Y., Ciftci, Y., Rowland-Pomp, M., Rustage, K., Goldsmith, L., Hartmann, M., Mounier-Jack, S., Burns, R., Miller, A., Wurie, F., Campos-Matos, I., Majeed, A., Hargreaves, S.
10.1101/2021.04.12.21255313 — Posted: 2021-04-19
Comparison of preprints and final journal publications from COVID-19 Studies: Discrepancies in results reporting and spin in interpretation
Bero, L., Lawrence, R., Leslie, L., Chiu, K., McDonald, S., Page, M., Grundy, Q., Parker, L., Boughton, S., Kirkham, J., Featherstone, R.
10.1101/2021.04.12.21255329 — Posted: 2021-04-19
The impact of population mobility on COVID-19 incidence and socioeconomic disparities at the sub-city level in 314 Latin American cities
Kephart, J. L., Delclos-Alio, X., Bilal, U., Sarmiento, O. L., Barrientos-Gutierrez, T., Ramirez-Zea, M., Quistberg, D. A., Rodriguez, D. A., Diez Roux, A. V.
10.1101/2021.04.13.21255413 — Posted: 2021-04-19
Outcomes of COVID-19 infection in patients treated with Clozapine.
Govind, R., Fonseca de Freitas, D., Pritchard, M., Khondoker, M., Teo, J. T., Stewart, R., Hayes, R. D., MacCabe, J. H.
10.1101/2021.04.13.21255384 — Posted: 2021-04-19
The multi-dimensional challenges of controlling SARS-CoV-2 transmission in indoor spaces: Insights from the linkage of a microscopic pedestrian simulation and virus transmission models
Duives, D., Chang, Y., Sparnaaij, M., Wouda, B., Boschma, D., Liu, Y., Yuan, Y., Daamen, W., de Jong, M. C. M., Teberg, C., Schachtschneider, K., Sikkema, R. S., van Veen, L., ten Bosch, Q.
10.1101/2021.04.12.21255349 — Posted: 2021-04-19
Assessing the impact of SARS-CoV-2 prevention measures in schools by means of agent-based simulations calibrated to cluster tracing data
Lasser, J., Sorger, J., Richter, L., Thurner, S., Schmid, D., Klimek, P.
10.1101/2021.04.13.21255320 — Posted: 2021-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).